Sponsor Pipeline

Wayshine Biopharm, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
3
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 2
1
Phase 1/2
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06868485 A Study to Assess the Efficacy of WSD0922-FU in Patients With C797S+ Advanced Non-small… Non Small Cell Lung Cancer Recruiting
Phase 1/2
NCT06631989 A Study to Assess the Efficacy and Safety of WSD0922-FU in Patients With EGFRm+ Advanced… EGFR Mutation Positive Advanced Non-Small Cell Lung Cancer Recruiting
NCT07206498 A Study to Evaluate Safety and Efficacy of WSD0922-FU Combo With Osimertinib for NSCLC Non Small Cell Lung Cancer (NSCLC) Recruiting
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (3) Lung Cancer (3)
Get alerts when Wayshine Biopharm, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free